Transenterix Stock Price, News & Analysis (NYSEAMERICAN:TRXC)

$2.17 -0.06 (-2.69 %)
(As of 12/11/2017 04:00 PM ET)
Previous Close$2.23
Today's Range$2.15 - $2.25
52-Week Range$0.45 - $5.00
Volume1.99 million shs
Average Volume3.23 million shs
Market Capitalization$444.31 million
P/E RatioN/A
Dividend YieldN/A
Beta1.98

About Transenterix (NYSEAMERICAN:TRXC)

Transenterix logoTransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Receive TRXC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRXC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:TRXC
CUSIPN/A
Phone+1-919-7658400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.62)
Net IncomeN/A
Net Margins-21,045.36%
Return on Equity-137.69%
Return on Assets-83.60%

Miscellaneous

EmployeesN/A
Outstanding Shares199,240,000

Transenterix (NYSEAMERICAN:TRXC) Frequently Asked Questions

What is Transenterix's stock symbol?

Transenterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."

How were Transenterix's earnings last quarter?

Transenterix Inc (NYSEAMERICAN:TRXC) posted its quarterly earnings data on Monday, March, 6th. The medical instruments supplier reported ($0.12) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.11) by $0.01. Transenterix had a negative return on equity of 137.69% and a negative net margin of 21,045.36%. View Transenterix's Earnings History.

Where is Transenterix's stock going? Where will Transenterix's stock price be in 2017?

3 brokerages have issued 1-year price targets for Transenterix's stock. Their forecasts range from $0.70 to $5.00. On average, they expect Transenterix's stock price to reach $3.23 in the next twelve months. View Analyst Ratings for Transenterix.

Are investors shorting Transenterix?

Transenterix saw a increase in short interest in November. As of November 30th, there was short interest totalling 14,893,810 shares, an increase of 7.4% from the November 15th total of 13,862,996 shares. Based on an average daily volume of 3,705,307 shares, the days-to-cover ratio is presently 4.0 days. Currently, 10.2% of the company's shares are sold short.

Who are some of Transenterix's key competitors?

Who are Transenterix's key executives?

Transenterix's management team includes the folowing people:

  • Paul A. LaViolette, Independent Chairman of the Board (Age 58)
  • Todd M. Pope, President, Chief Executive Officer, Director (Age 49)
  • Joseph P. Slattery CPA, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 50)
  • Anthony Fernando, Chief Operating Officer
  • Andrea Biffi, Director
  • Dennis J. Dougherty, Independent Director (Age 56)
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • William N. Kelley M.D., Independent Director (Age 77)
  • Aftab R. Kherani M.D., Independent Director (Age 41)

Who owns Transenterix stock?

Transenterix's stock is owned by a number of of retail and institutional investors. Top institutional investors include Ladenburg Thalmann Financial Services Inc. (0.05%). Company insiders that own Transenterix stock include Andrea Biffi, Anthony C J Fernando, Joseph P Slattery, Richard C Pfenniger Jr, SPA Sofar, Todd Pope and Willam N Kelley. View Institutional Ownership Trends for Transenterix.

Who bought Transenterix stock? Who is buying Transenterix stock?

Transenterix's stock was bought by a variety of institutional investors in the last quarter, including Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Transenterix stock in the last two years include Andrea Biffi, Anthony C J Fernando, Joseph P Slattery, Richard C Pfenniger Jr, SPA Sofar and Willam N Kelley. View Insider Buying and Selling for Transenterix.

How do I buy Transenterix stock?

Shares of Transenterix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transenterix's stock price today?

One share of Transenterix stock can currently be purchased for approximately $2.17.

How big of a company is Transenterix?

Transenterix has a market capitalization of $444.31 million.

How can I contact Transenterix?

Transenterix's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier can be reached via phone at +1-919-7658400.


MarketBeat Community Rating for Transenterix (TRXC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  239
MarketBeat's community ratings are surveys of what our community members think about Transenterix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Transenterix (NYSEAMERICAN:TRXC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.672.602.252.25
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.23$2.93$2.90$2.90
Price Target Upside: 12.66% upside1.92% upside446.24% upside446.24% upside

Transenterix (NYSEAMERICAN:TRXC) Consensus Price Target History

Price Target History for Transenterix (NYSEAMERICAN:TRXC)

Transenterix (NYSEAMERICAN:TRXC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/31/2017Stifel NicolausBoost Price TargetBuy$3.75 -> $4.00View Rating Details
10/20/2017Ladenburg Thalmann Financial ServicesSet Price TargetBuy$5.00View Rating Details
5/16/2017B. RileyDowngradeNeutral$0.70View Rating Details
1/19/2017Raymond James FinancialDowngradeOutperform -> Mkt PerformView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details
5/11/2016Lake Street CapitalDowngradeBuy -> Hold$2.00View Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> Neutral$6.00View Rating Details
(Data available from 12/11/2015 forward)

Earnings

Transenterix (NYSEAMERICAN:TRXC) Earnings History and Estimates Chart

Earnings by Quarter for Transenterix (NYSEAMERICAN:TRXC)

Transenterix (NYSEAMERICAN TRXC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017Q4 2016($0.11)($0.12)ViewListenView Earnings Details
11/9/2016Q316($0.10)($0.11)$1.80 million$1.50 millionViewListenView Earnings Details
5/10/2016Q116($0.13)($0.12)ViewListenView Earnings Details
3/3/2016Q415($0.12)($0.13)ViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.14)ViewN/AView Earnings Details
5/6/2015Q115($0.17)($0.16)$0.03 millionViewN/AView Earnings Details
2/24/2015Q414($0.18)($0.13)$50.00 million$0.13 millionViewN/AView Earnings Details
11/6/2014Q3($0.18)($0.18)$0.10 million$0.06 millionViewN/AView Earnings Details
5/7/2014($0.14)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Transenterix (NYSEAMERICAN:TRXC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Transenterix (NYSEAMERICAN:TRXC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Transenterix (NYSEAMERICAN TRXC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Transenterix (NYSEAMERICAN:TRXC)

Transenterix (NYSEAMERICAN TRXC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2017Joseph P SlatteryCFOSell529,609$2.80$1,482,905.20View SEC Filing  
11/14/2017Joseph P SlatteryCFOSell333,000$2.93$975,690.00View SEC Filing  
10/18/2017Todd PopeInsiderSell600,000$3.68$2,208,000.00View SEC Filing  
8/8/2017Willam N KelleyDirectorBuy30,000$0.71$21,300.00View SEC Filing  
5/16/2017Richard C Pfenniger JrDirectorBuy100,000$0.54$54,000.00View SEC Filing  
1/4/2017S.P.A SofarMajor ShareholderBuy3,722,685$1.40$5,211,759.00View SEC Filing  
8/22/2016Andrea BiffiDirectorBuy40,000$1.40$56,000.00View SEC Filing  
6/14/2016Anthony C J FernandoCTOBuy27,000$1.46$39,420.00View SEC Filing  
5/13/2016Joseph P SlatteryCFOBuy50,000$1.92$96,000.00View SEC Filing  
11/16/2015Andrea BiffiDirectorBuy25,000$2.81$70,250.00View SEC Filing  
11/13/2015Willam N KelleyDirectorBuy20,000$2.80$56,000.00View SEC Filing  
11/12/2015Joseph P SlatteryCFOBuy15,000$2.77$41,550.00View SEC Filing  
10/2/2014Joseph P SlatteryCFOSell33,000$4.19$138,270.00View SEC Filing  
9/8/2014Richard MuellerCOOSell3,000$3.60$10,800.00View SEC Filing  
9/8/2014Todd PopeCEOSell50,000$3.70$185,000.00View SEC Filing  
4/21/2014Aisling Capital Iii LpMajor ShareholderBuy1,037,767$4.00$4,151,068.00View SEC Filing  
4/21/2014William N Starling JrDirectorBuy221,450$4.00$885,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Transenterix (NYSEAMERICAN TRXC) News Headlines

Source:
DateHeadline
Transenterix Inc (TRXC) Short Interest Up 7.4% in NovemberTransenterix Inc (TRXC) Short Interest Up 7.4% in November
www.americanbankingnews.com - December 11 at 8:36 PM
7 ‘Strong Buy’ Disruptive Stocks You Should Track Now7 ‘Strong Buy’ Disruptive Stocks You Should Track Now
finance.yahoo.com - December 8 at 3:30 PM
ETFs with exposure to TransEnterix, Inc. : December 8, 2017ETFs with exposure to TransEnterix, Inc. : December 8, 2017
finance.yahoo.com - December 8 at 3:30 PM
Heres Why TransEnterix Inc. Stock Tanked 22% in DecemberHere's Why TransEnterix Inc. Stock Tanked 22% in December
www.fool.com - December 7 at 4:22 PM
Here's Why TransEnterix Inc. Stock Tanked 22% in DecemberHere's Why TransEnterix Inc. Stock Tanked 22% in December
finance.yahoo.com - December 7 at 3:35 PM
TransEnterix, Senhance Marketing Underway, Expanded Indications Planned for Early 2018TransEnterix, Senhance Marketing Underway, Expanded Indications Planned for Early 2018
finance.yahoo.com - December 7 at 9:05 AM
35 Stocks Moving In Wednesdays Pre-Market Session35 Stocks Moving In Wednesday's Pre-Market Session
feeds.benzinga.com - November 29 at 8:23 AM
ETFs with exposure to TransEnterix, Inc. : November 27, 2017ETFs with exposure to TransEnterix, Inc. : November 27, 2017
finance.yahoo.com - November 28 at 8:31 AM
Transenterix Inc (TRXC) Sees Large Increase in Short InterestTransenterix Inc (TRXC) Sees Large Increase in Short Interest
www.americanbankingnews.com - November 27 at 8:24 PM
Transenterix Undisclosed Related Party Transactions - Seeking Alpha - Seeking AlphaTransenterix Undisclosed Related Party Transactions - Seeking Alpha - Seeking Alpha
seekingalpha.com - November 27 at 3:20 PM
Edited Transcript of TRXC earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of TRXC earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 20 at 11:25 AM
Transenterix Inc (TRXC) CFO Joseph P. Slattery Sells 529,609 SharesTransenterix Inc (TRXC) CFO Joseph P. Slattery Sells 529,609 Shares
www.americanbankingnews.com - November 16 at 10:36 PM
Transenterix Inc (TRXC) CFO Joseph P. Slattery Sells 333,000 SharesTransenterix Inc (TRXC) CFO Joseph P. Slattery Sells 333,000 Shares
www.americanbankingnews.com - November 16 at 10:33 PM

SEC Filings

Transenterix (NYSEAMERICAN:TRXC) SEC Filings

DateFilerForm TypeView

Social Media

Financials

Transenterix (NYSEAMERICAN:TRXC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Transenterix (NYSEAMERICAN TRXC) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.